ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT

Abstract

Abnormal endothelial function occurs in patients with coronary artery disease, and this can be counteracted by angiotensin-converting enzyme inhibition with perindopril. These effects could contribute, at least in part, to explaining the results of the main EUROPA Study.